GLYC

GlycoMimetics, Inc. News Headlines

$9.4
*  
0.25
2.73%
Get GLYC Alerts
*Delayed - data as of Nov. 26, 2014  -  Find a broker to begin trading GLYC now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    GLYC After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Why Imminent Orphan Status Designation Will Attract Big Pharma To Mast Therapeutics
10/1/2014 10:45:00 AM - Seeking Alpha


AMBI Snapped Up, ALIM''s Iluvien Gets FDA Nod, GLYC Faces Glitch In Study
9/29/2014 2:04:00 AM - RTT News


GlycoMimetics Reports Delay In Initiation Of Phase 3 Trial With Rivipansel
9/26/2014 9:06:00 AM - RTT News


BioMed Realty Inks Lease Agreement with GlycoMimetics in MD - Analyst Blog
8/29/2014 4:20:00 PM - Zacks.com


Friday Sector Leaders: Manufacturing, Drugs
7/18/2014 1:07:24 PM - BNK Invest


Sector Update: Health Care
7/18/2014 12:33:31 PM - MT Newswires


Sector Update: Health Care Stocks Following Broader Markets Highers; GlycoMimetics Jumps More Than 10% After Naming Cancer-Specialist to Board
7/18/2014 12:32:37 PM - MT Newswires


GlycoMimetics Up on FDA Agreement on Rivipansel Study - Analyst Blog
7/2/2014 3:50:00 PM - Zacks.com


Sector Update: Healthcare
5/21/2014 7:53:17 AM - MT Newswires


How GlycoMimetics (GLYC) Stock Stands Out in a Strong Industry - Tale of the Tape
4/11/2014 7:39:01 AM - Zacks.com


GlycoMimetics: A Promising Sickle Cell Disease Play
4/10/2014 9:39:00 AM - Seeking Alpha


Should GlycoMimetics (GLYC) Be On Your Radar Now? - Tale of the Tape
4/10/2014 7:48:01 AM - Zacks.com


Biotechs Dominate IPO Calendar, But Most Post Negative Returns
2/6/2014 11:45:00 AM - Seeking Alpha


Biotechs dominate IPO calendar, but most post negative returns
2/6/2014 8:57:52 AM - Renaissance Capital


U.S. IPO Recap: 20 Companies File Or Set Terms For IPOs
1/14/2014 7:31:00 AM - Seeking Alpha


4 U.S. IPOs Planned For The Week Of Jan. 13
1/14/2014 7:03:00 AM - Seeking Alpha


US IPO Recap: Twenty companies file or set terms for IPOs
1/13/2014 8:26:01 AM - Renaissance Capital


4 US IPOs planned for the week of Jan 13
1/13/2014 7:00:03 AM - Renaissance Capital


GlycoMimetics prices upsized IPO at $8 per share
1/10/2014 7:46:55 AM - Renaissance Capital


GlycoMimetics drops IPO price to $8 and increases shares offered
1/7/2014 8:13:02 AM - Renaissance Capital


Orphan disease biotech GlycoMimetics revives IPO filing, removes original terms
12/20/2013 7:54:07 AM - Renaissance Capital


GlycoMimetics postpones $60 million IPO
11/8/2013 7:12:03 AM - Renaissance Capital


15 U.S. IPOs Planned For The Week Of Nov. 4
11/5/2013 7:57:00 AM - Seeking Alpha


Orphan disease biotech GlycoMimetics sets terms for $60 million IPO
10/28/2013 7:12:38 AM - Renaissance Capital